Comparison of administration of oral versus Infusions intravenous iron therapy in diabetic patients with chronic kidney disease receiving Erythropoietin

IV iron therapy was significantly more effective and show superior efficacy in older patients, males, and those with longer diabetes mellitus duration than oral therapy in improving anemia-related complications in diabetic patients with CKD receiving Erythropoietin, making it a preferable treatment choice in this population.